Working Together to Meet the Needs of Patients With Inflammatory Bowel Diseases
Public Deposited- Creator
- Brenner, E.J.
-
Kappelman, M.D.
- Affiliation: Center for Gastrointestinal Biology and Disease
- Abstract
- We read with interest the article entitled "Coronavirus Disease 2019 (COVID-19): What Should Gastroenterologists and Their Patients Know" by Ungaro et al. The authors provided an informative and concise overview of COVID-19 through the lens of the gastroenterologist. Importantly, they highlighted the paucity of data on the impact of COVID-19 on patients with gastrointestinal disease, including inflammatory bowel disease (IBD). Because COVID-19 is a novel virus, it remains unclear how it will affect our patients, particularly those on immunosuppressive medications. The global gastroenterology community currently lacks the data needed to answer the most pressing questions from our patients: whether their disease places them at higher risk of poor outcomes from COVID-19 and whether they should stop or change current medications.
- Date of publication
- 2020
- DOI
- Identifier
- https://dx.doi.org/10.1016/j.cgh.2020.03.055
- PMID 32246997
- Resource type
- Article
- Rights statement
- In Copyright
- Journal title
- Clinical Gastroenterology and Hepatology
- Language
- English
- ISSN
- 1542-3565
- Publisher
- W.B. Saunders
Relations
- Parents:
- In Collection:
This work has no parents.
Items
| Thumbnail | Title | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|
|
|
1-s2.0-S1542356520304328-main.pdf | 2020-09-22 | Public | Download |